Skip to content
Screener

G&A at other companies

InfuSystem Holdings logo
InfuSystem HoldingsINFU
$14.8M-3.3%
AngioDynamics logo
AngioDynamicsANGO
$10.27M+0.3%
TriSalus Life Sciences, Inc. logo
TriSalus Life Sciences, Inc.TLSI
$5.45M+3.9%
CTO
Citius Oncology, Inc.CTOR
$23.63M+953%
TTR
Turn Therapeutics Inc.TTRX
$1.14M+203%
Savara logo
SavaraSVRA
$18.99M+78.2%

Other financials

Income statement

See full
Revenue$85.7M+8.6%
Gross profit$65.3M+11.2%
Operating income$6.8M+67.2%
Net income$7.8M+142%
EPS (diluted)$0.34+143%

Balance sheet

See full
Cash & equivalents$69.9M-14.3%
Total debt$14.4M-63.4%
Total equity$223.8M+14.8%
Total assets$279.7M+2.4%

Cash flow

See full
Operating cash flow$3.3M-77.9%
CapEx$1.3M+247%
Free cash flow$2.0M-86.3%

Valuation

See full
Market cap$657.29M+142%
Enterprise value$601.8M+163%
P/E26.4×+8.5×
P/S1.9×+1.0×

Profitability

See full
Gross margin76.8%+2.1pp
Operating margin10%+3.7pp
Net margin7.1%+2.0pp
FCF margin7.7%-5.6pp

Returns & leverage

See full
Return on equity11.9%+4.2pp
Debt / equity0.1×-0.1×
Current ratio4.1×+0.3×

Where this comes from

Reported directly by Tactile Systems Technology in its filing.

Tagged under the XBRL concept us-gaap:GeneralAndAdministrativeExpense.

The source filing: Tactile Systems Technology’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:06 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001104659-26-093352
(In thousands, except share and per share data)Three Months Ended / June 30, 2026Three Months Ended / June 30, 2025Six Months Ended / June 30, 2026Six Months Ended / June 30, 2025
Operating expenses
Sales and marketing32,01230,03964,74457,555
Research and development2,5012,0185,2773,759
Reimbursement, general and administrative23,36022,03446,40442,032
Intangible asset amortization and earn-out6506191,2461,252
Total operating expenses58,52354,710117,671104,598
Income (loss) from operations6,8264,0835,292(459)
Interest income5618501,2271,745

Item 1. Financial Statements

FAQ

What is Tactile Systems Technology's G&A?
Tactile Systems Technology (TCMD) reported G&A of $23.36M in Q2 2026.
How has Tactile Systems Technology's G&A changed year-over-year?
Tactile Systems Technology's G&A increased by 6.0% year-over-year, from $22.03M to $23.36M.
What is the long-term trend for Tactile Systems Technology's G&A?
Over 4 years (2021 to 2025), Tactile Systems Technology's G&A has grown at a 11.8% compound annual growth rate (CAGR), from $56.8M to $88.71M.
What does G&A mean?
Overhead costs not directly tied to production or sales — corporate management, legal, accounting, office rent, insurance, and other administrative functions.

Ask your AI about Tactile Systems Technology's g&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude